Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · see citing works

International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · see citing works

Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product

Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486 · see citing works

Novel Receptor Partners and Function of Receptor Activity-modifying Proteins

Christopoulos, A., Christopoulos, G., Morfis, M. M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309 · see citing works

GPCR interacting proteins (GIP)

Bockaert, J., Fagni, L., Dumuis, A., & Marin, P. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.004 · Cited by 262 · see citing works

GPCR modulation by RAMPs

Hay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239 · see citing works

Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes

Hay, D. L., Christopoulos, G., Christopoulos, A., Poyner, D. R., & Sexton, P. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008615 · Cited by 212 · see citing works

ACCESSORY PROTEINS FOR G PROTEINS: Partners in Signaling

Sato, M., Blumer, J., Simon, V., & Lanier, S. M. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141115 · Cited by 173 · see citing works

Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment

Tilakaratne, N., Christopoulos, G., van der Westhuizen, E. T., Foord, S. M., & Sexton, P. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39040-8 · Cited by 165 · see citing works

Calcitonin

Sexton, P. M., Findlay, D. M., & Martin, T. J. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730611220401164504 · Cited by 164 · see citing works

Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript

Moore, E. E., Kuestner, R. E., Stroop, S. D., Grant, F. J., Matthewes, S. L., Brady, C. L., Sexton, P. M., & Findlay, D. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.8.7476993 · Cited by 104 · see citing works

The Relaxin Family Peptide Receptor 3 Activates Extracellular Signal-Regulated Kinase 1/2 through a Protein Kinase C-Dependent Mechanism

van der Westhuizen, E. T., Werry, T. D., Sexton, P. M., & Summers, R. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032763 · Cited by 93 · see citing works

Characterization of serotonin 5‐HT2Creceptor signaling to extracellular signal‐regulated kinases 1 and 2

Werry, T. D., Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03161.x · Cited by 89 · see citing works

Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes.

Bhogal, R., Smith, D. M., & Bloom, S. R. (1992) · Endocrinology · doi:10.1210/endo.130.2.1310282 · Cited by 73 · see citing works

Multiple Ramp Domains Are Required for Generation of Amylin Receptor Phenotype from the Calcitonin Receptor Gene Product

van der Westhuizen, E. T., Tilakaratne, N., Fraser, N. J., Christopoulos, G., Foord, S. M., & Sexton, P. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1943 · Cited by 72 · see citing works

Distinct Receptor Activity-Modifying Protein Domains Differentially Modulate Interaction with Calcitonin Receptors

Udawela, M., Christopoulos, G., Tilakaratne, N., Christopoulos, A., Albiston, A. L., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021915 · Cited by 60 · see citing works

A Critical Role for the Short Intracellular C Terminus in Receptor Activity-Modifying Protein Function

Udawela, M., Christopoulos, G., Morfis, M. M., Christopoulos, A., Ye, S., Tilakaratne, N., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024257 · Cited by 43 · see citing works

Characterization of Amylin and Calcitonin Receptor Binding in the Mouse α-Thyroid-Stimulating Hormone Thyrotroph Cell Line*

Perry, K. J., Quiza, M., Myers, D. E., Morfis, M. M., Christopoulos, G., & Sexton, P. M. (1997) · Endocrinology · doi:10.1210/endo.138.8.5312 · Cited by 41 · see citing works

Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor

Pham, V., Wade, J. D., Purdue, B. W., & Sexton, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307214200 · Cited by 39 · see citing works

G‐Protein‐coupled receptor–protein interactions: Basis for new concepts on receptor structure and function

Tilakaratne, N., & Sexton, P. M. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04295.x · Cited by 37 · see citing works

Amylin: Physiology and Pharmacology

(2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)x1064-x · Cited by 29 · see citing works

Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor

Raggatt, L., Evdokiou, A., & Findlay, D. M. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670093 · Cited by 29 · see citing works

Pramlintide: A new tool in diabetes management

Want, L. L., & Ratner, R. E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0004-0 · Cited by 7 · see citing works

Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus

Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044 · see citing works

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors

Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 555 · see citing works

Amylin: Pharmacology, Physiology, and Clinical Potential

Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400 · see citing works

CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond

Russo, A. F., & Hay, D. L. (2022) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 395 · see citing works

Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening

Koole, C., Wootten, D. L., Simms, J., Valant, C., Sridhar, R., Woodman, O. L., Miller, L. J., Summers, R. J., Christopoulos, A., & Sexton, P. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065664 · Cited by 225 · see citing works

Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery

Slosky, L. M., Caron, M. G., & Barak, L. S. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.12.005 · Cited by 214 · see citing works

Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles

Hay, D. L., & Pioszak, A. A. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 191 · see citing works

Regulation of signal transduction by calcitonin gene-related peptide receptors

Walker, C. S., Conner, A. C., Poyner, D. R., & Hay, D. L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.006 · Cited by 157 · see citing works

Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics

Tao, Y., & Conn, P. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1121 · Cited by 146 · see citing works

The Activity of Peptides of the Calcitonin Family in Bone

Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141 · see citing works

Endogenous Allosteric Modulators of G Protein–Coupled Receptors

van der Westhuizen, E. T., Valant, C., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221606 · Cited by 144 · see citing works

Control of energy homeostasis by amylin

Lutz, T. A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0905-1 · Cited by 136 · see citing works

Allostery and biased agonism at class B G protein-coupled receptors

Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112 · see citing works

Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

Bower, R. L., & Hay, D. L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13496 · Cited by 104 · see citing works

Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes

Bailey, R., Walker, C. S., Ferner, A. H., Loomes, K., Prijic, G., Halim, A., Whiting, L., Phillips, A., & Hay, D. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01717.x · Cited by 102 · see citing works

Modulation of immune responses by the neuropeptide CGRP

Holzmann, B. (2011) · Amino Acids · doi:10.1007/s00726-011-1161-2 · Cited by 101 · see citing works

Amyloid β (Aβ) Peptide Directly Activates Amylin-3 Receptor Subtype by Triggering Multiple Intracellular Signaling Pathways

Fu, W., Ruangkittisakul, A., MacTavish, D., Shi, J., Ballanyi, K., & Jhamandas, J. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331181 · Cited by 93 · see citing works

A structural basis for amylin receptor phenotype

Cao, J., Belousoff, M. J., Liang, Y.-L., Johnson, R. M., Josephs, T. M., Fletcher, M. M., Christopoulos, A., Hay, D. L., Danev, R., Wootten, D. L., et al. (2022) · Science · doi:10.1126/science.abm9609 · Cited by 92 · see citing works

Brainstem mechanisms of amylin-induced anorexia

Potes, C. S., & Lutz, T. A. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.001 · Cited by 91 · see citing works

G PROTEIN‐COUPLED RECEPTORS

Alexander, S., Mathie, A. A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_3.x · Cited by 88 · see citing works

Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins

Liang, Y.-L., Belousoff, M. J., Fletcher, M. M., Zhang, X., Khoshouei, M., Deganutti, G., Koole, C., Furness, S. G. B., Miller, L. J., Hay, D. L., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00080 · Cited by 87 · see citing works

Receptor activity modifying proteins ( RAMPs ) interact with the VPAC 2receptor and CRF 1receptors and modulate their function

Wootten, D. L., Lindmark, H., Kadmiel, M., Willcockson, H. H., Caron, K. M., Barwell, J., Drmota, T., & Poyner, D. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02202.x · Cited by 83 · see citing works

Actions of β-Amyloid Protein on Human Neurons Are Expressed through the Amylin Receptor

Jhamandas, J. H., Li, Z., Westaway, D. A., Yang, J., Jassar, S., & MacTavish, D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.022 · Cited by 82 · see citing works

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01525.x · Cited by 80 · see citing works

Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin

Bower, R. L., Yule, L. R., Rees, T. A., Deganutti, G., Hendrikse, E. R., Harris, P. W. R., Kowalczyk, R., Ridgway, Z. M., Wong, A. G., Swierkula, K., et al. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00002 · Cited by 80 · see citing works

Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)

Weston, C. A., Lu, J. N., Li, N., Barkan, K., Richards, G. O., Roberts, D. J., Skerry, T. M., Poyner, D. R., Pardamwar, M., Reynolds, C. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624601 · Cited by 77 · see citing works

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Lee, S. M., Hay, D. L., & Pioszak, A. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713628 · Cited by 76 · see citing works

Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations

Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 73 · see citing works

Modulating receptor function through RAMPs: can they represent drug targets in themselves?

Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.009 · Cited by 72 · see citing works

AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists

Fletcher, M. M., Keov, P., Truong, T. T., Mennen, G., Hick, C. A., Zhao, P., Furness, S. G. B., Kruse, T., Clausen, T. R., Wootten, D. L., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000567 · Cited by 68 · see citing works

Amylin activates distributed CNS nuclei to control energy balance

Mietlicki‐Baase, E. G., & Hayes, M. R. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.01.013 · Cited by 66 · see citing works

Amylin receptor components and the leptin receptor are co‐expressed in single rat area postrema neurons

Liberini, C. G., Boyle, C. N., Cifani, C., Vènniro, M., Hope, B. T., & Lutz, T. A. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13163 · Cited by 66 · see citing works

An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

Gingell, J. J., Simms, J., Barwell, J., Poyner, D. R., Watkins, H. A., Pioszak, A. A., Sexton, P. M., & Hay, D. L. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.12 · Cited by 60 · see citing works

Creating the amylin story

Lutz, T. A. (2022) · Appetite · doi:10.1016/j.appet.2022.105965 · Cited by 59 · see citing works

Activity of Pramlintide, Rat and Human Amylin but not Aβ1–42 at Human Amylin Receptors

Gingell, J. J., Hendrikse, E. R., & Hay, D. L. (2013) · Endocrinology · doi:10.1210/en.2013-1658 · Cited by 58 · see citing works

Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40.

Yan, L.-M., Velkova, A., Tatarek-Nossol, M., Rammes, G., Sibaev, A., Andreetto, E., Kracklauer, M., Bakou, M., Malideli, E., Göke, B., et al. (2013) · Angewandte Chemie · doi:10.1002/anie.201302840 · Cited by 55 · see citing works

Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling

Reiner, D. J., Mietlicki‐Baase, E. G., Olivos, D. R., McGrath, L. E., Zimmer, D. J., Koch‐Laskowski, K., Krawczyk, J., Turner, C. A., Noble, E. E., Hahn, J. D., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.028 · Cited by 53 · see citing works

Involvement of the extracellular signal-regulated kinase 1/2 signaling pathway in amylin's eating inhibitory effect

Potes, C. S., Boyle, C. N., Wookey, P. J., Riediger, T., & Lutz, T. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00380.2011 · Cited by 51 · see citing works

Amylin and Leptin: Co-Regulators of Energy Homeostasis and Neuronal Development

Levin, B. E., & Lutz, T. A. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.004 · Cited by 49 · see citing works

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Pioszak, A. A., & Hay, D. L. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.01.001 · Cited by 49 · see citing works

The Molecular Control of Calcitonin Receptor Signaling

Maso, E. D., Glukhova, A., Zhu, Y., García‐Nafría, J., Tate, C. G., Atanasio, S., Reynolds, C. A., Ramírez-Aportela, E., Carazo, J. M., Hick, C. A., et al. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00056 · Cited by 48 · see citing works

Molecular Basis of Association of Receptor Activity-Modifying Protein 3 with the Family B G Protein-Coupled Secretin Receptor

Harikumar, K. G., Simms, J., Christopoulos, G., Sexton, P. M., & Miller, L. J. (2009) · Biochemistry · doi:10.1021/bi901326k · Cited by 48 · see citing works

Receptor activity‐modifying protein‐dependent impairment of calcitonin receptor splice variant Δ(1–47) hCT (a)function

Qi, T., Dong, M., Watkins, H. A., Wootten, D. L., Miller, L., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02197.x · Cited by 47 · see citing works

Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins

Kotliar, I. B., Lorenzen, E., Schwenk, J. M., Hay, D. L., & Sakmar, T. P. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000180 · Cited by 46 · see citing works

Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights

Geisler, C. E., & Hayes, M. R. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114236 · Cited by 45 · see citing works

β-Amyloid protein (Aβ) and human amylin regulation of apoptotic genes occurs through the amylin receptor

Jhamandas, J. H., & MacTavish, D. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0656-3 · Cited by 45 · see citing works

Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins

Hay, D. L., Walker, C. S., Gingell, J. J., Ladds, G., Reynolds, C. A., & Poyner, D. R. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150237 · Cited by 45 · see citing works

PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells

Walker, C. S., Sundrum, T., & Hay, D. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12541 · Cited by 43 · see citing works

Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity

Dunn-Meynell, A. A., Foll, C. L., Johnson, M. D., Lutz, T. A., Hayes, M. R., & Levin, B. E. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00462.2015 · Cited by 43 · see citing works

The expanding repertoire of receptor activity modifying protein (RAMP) function

Klein, K. R., Matson, B. C., & Caron, K. M. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1128875 · Cited by 39 · see citing works

Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors

Garelja, M. L., Au, M., Brimble, M. A., Gingell, J. J., Hendrikse, E. R., Lovell, A., Prodan, N., Sexton, P. M., Siow, A., Walker, C. S., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00083 · Cited by 40 · see citing works

Pharmacological characterisation of mouse calcitonin and calcitonin receptor‐like receptors reveals differences compared with human receptors

Garelja, M. L., Bower, R. L., Brimble, M. A., Chand, S., Harris, P. W. R., Jamaluddin, A., Petersen, J. S. S. M., Siow, A., Walker, C. S., & Hay, D. L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15628 · Cited by 38 · see citing works

Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases

Zakariassen, H. L., John, L. M., & Lutz, T. A. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13427 · Cited by 37 · see citing works

Amylin Receptor Signaling in the Nucleus Accumbens Negatively Modulates μ-opioid-Driven Feeding

Baisley, S. K., & Baldo, B. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.153 · Cited by 36 · see citing works

Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae

Sekiguchi, T., Kuwasako, K., Ogasawara, M., Takahashi, H., Matsubara, S., Osugi, T., Muramatsu, I., Sasayama, Y., Suzuki, N., & Satake, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664003 · Cited by 36 · see citing works

RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling

Cegla, J., Jones, B. J., Gardiner, J., Hodson, D. J., Marjot, T., McGlone, E. R., Tan, T., & Bloom, S. R. (2017) · Endocrinology · doi:10.1210/en.2016-1755 · Cited by 36 · see citing works

Translational neuropharmacology: the use of human isolated gastrointestinal tissues

Sanger, G. J., Broad, J., Kung, V., & Knowles, C. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02198.x · Cited by 36 · see citing works

Structure–function relationships of the N‐terminus of receptor activity‐modifying proteins

Qi, T., & Hay, D. L. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00541.x · Cited by 36 · see citing works

Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs

Woolley, M. J., Reynolds, C. A., Simms, J., Walker, C. S., Mobarec, J. C., Garelja, M. L., Conner, A. C., Poyner, D. R., & Hay, D. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.005 · Cited by 35 · see citing works

Distinct Internalization Pathways of Human Amylin Monomers and Its Cytotoxic Oligomers in Pancreatic Cells

Trikha, S., & Jeremic, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073080 · Cited by 34 · see citing works

Loss-of-Function Mutations in Calcitonin Receptor ( CALCR ) Identify Highly Aggressive Glioblastoma with Poor Outcome

Pal, J., Patil, V. S., Kumar, A., Kaur, K., Sarkar, C., & Somasundaram, K. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1901 · Cited by 34 · see citing works

Molecular chaperones and G protein-coupled receptor maturation and pharmacology

Tao, Y. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110862 · Cited by 31 · see citing works

Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy

Maso, E. D., Zhu, Y., Pham, V., Reynolds, C. A., Deganutti, G., Hick, C. A., Yang, D., Christopoulos, A., Hay, D. L., Wang, M.-W., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.005 · Cited by 30 · see citing works

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

Mietlicki‐Baase, E. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.016 · Cited by 29 · see citing works

A selective role for receptor activity‐modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice

Arrigoni, S., Foll, C. L., Cabak, A., Lundh, S. H., Raun, K., John, L. M., & Lutz, T. A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15376 · Cited by 27 · see citing works

Amylin Modulates a Ventral Tegmental Area–to–Medial Prefrontal Cortex Circuit to Suppress Food Intake and Impulsive Food-Directed Behavior

Geisler, C. E., Décarie-Spain, L., Loh, M. K., Trumbauer, W., Gaisinsky, J., Klug, M. E., Pelletier, C., Davis, J. F., Schmidt, H. D., Roitman, M. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.07.011 · Cited by 24 · see citing works

Understanding RAMPs Through Genetically Engineered Mouse Models

Kadmiel, M., Fritz-Six, K. L., & Caron, K. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_5 · Cited by 24 · see citing works

The calcitonin-like system is an ancient regulatory system of biomineralization

Cardoso, J. C. R., Félix, R. C., Ferreira, V., Peng, M., Zhang, X., & Power, D. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-64118-w · Cited by 23 · see citing works

The Extracellular Calcium-Sensing Receptor (CASR) Regulates Gonadotropins-Induced Meiotic Maturation of Porcine Oocytes1

Liu, C., Wu, G., Fu, X., Mo, X., Zhao, L., Hu, H., Zhu, S., & Hou, Y. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.128579 · Cited by 21 · see citing works

Activated human hydroxy‐carboxylic acid receptor‐3 signals to MAP kinase cascades via the PLC‐dependent PKC and MMP‐mediated EGFR pathways

Zhou, Q., Li, G., Deng, X., He, X., Chen, L., Wu, C. J., Shi, Y., Wu, K., Mei, L., Lu, J., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01875.x · Cited by 21 · see citing works

Blocking Inflammasome Activation Caused by β-Amyloid Peptide (Aβ) and Islet Amyloid Polypeptide (IAPP) through an IAPP Mimic

Aftabizadeh, M., Tatarek‐Nossol, M., Andreetto, E., Bounkari, O. E., Kipp, M., Beyer, C., Latz, E., Bernhagen, J., & Kapurniotu, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00260 · Cited by 20 · see citing works

Whole‐brain mapping of amylin‐induced neuronal activity in receptor activity–modifying protein 1/3 knockout mice

Skovbjerg, G., Roostalu, U., Hansen, H. H., Lutz, T. A., Foll, C. L., Salinas, C. G., Skytte, J. L., Jelsing, J., Vrang, N., & Hecksher‐Sørensen, J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15254 · Cited by 19 · see citing works

Islet amyloid toxicity: From genesis to counteracting mechanisms

Marmentini, C., Branco, R. C. S., Boschero, A. C., & Kurauti, M. A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30600 · Cited by 19 · see citing works

Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas

Ostrovskaya, A., Hick, C. A., Hutchinson, D. S., Stringer, B. W., Wookey, P. J., Wootten, D. L., Sexton, P. M., & Furness, S. G. B. (2019) · BMC Cancer · doi:10.1186/s12885-019-5369-y · Cited by 19 · see citing works

Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis

Singh, S., Trikha, S., Bhowmick, D. C., Sarkar, A. A., & Jeremic, A. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_4 · Cited by 18 · see citing works

RAMPs regulate signalling bias and internalisation of the GIPRPreprint

Harris, M., Mackie, D. I., Pawlak, J. B., Carvalho, S., Truong, T. T., Safitri, D., Yeung, H. Y., Routledge, S. J., Harper, M. T., Al‐Zaid, B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.08.436756 · Cited by 19 · see citing works

Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism

Foll, C. L., & Lutz, T. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190034 · Cited by 27 · see citing works

The effects of RAMPs upon cell signalling

Routledge, S. J., Ladds, G., & Poyner, D. R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.033 · Cited by 16 · see citing works

Receptor Activity Modifying Proteins and Their Potential as Drug Targets

Wootten, D. L., Simms, J., Hay, D. L., Christopoulos, A., & Sexton, P. M. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)91003-x · Cited by 14 · see citing works

RAMPs as Drug Targets

Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_6 · Cited by 13 · see citing works

Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells

Krizhanovskii, C., Fred, R. G., Oskarsson, M. E., Westermark, G. T., & Welsh, N. (2017) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2017.1368745 · Cited by 12 · see citing works

Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors

Lee, S. M. (2021) · Biomolecules · doi:10.3390/biom11091364 · Cited by 12 · see citing works

RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency

Chidiac, P. (2015) · Methods · doi:10.1016/j.ymeth.2015.08.011 · Cited by 12 · see citing works

Deconvoluting the Molecular Control of Binding and Signaling at the Amylin 3 Receptor: RAMP3 Alters Signal Propagation through Extracellular Loops of the Calcitonin Receptor

Pham, V., Zhu, Y., Maso, E. D., Reynolds, C. A., Deganutti, G., Atanasio, S., Hick, C. A., Yang, D., Christopoulos, A., Hay, D. L., et al. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00010 · Cited by 12 · see citing works

Functional characterization of two human receptor activity-modifying protein 3 variants

Bailey, R. J., Bradley, J., Poyner, D. R., Rathbone, D. L., & Hay, D. L. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.016 · Cited by 12 · see citing works

The role of amylin, a gut–brain axis hormone, in metabolic and neurological disorders

Muhammad, T., Pastore, S. F., Good, K., Yu, W. H., & Vincent, J. B. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00151 · Cited by 11 · see citing works

Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors

Piper, N. B. C., Whitfield, E. A., Stewart, G. D., Xu, X., & Furness, S. G. B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115115 · Cited by 11 · see citing works

Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C

Giansanti, M., Gabrieli, A. D., Prete, S. P., Ottone, T., Divona, M. D., Karimi, T., Ciccarone, F., Voso, M. T., Graziani, G., & Faraoni, I. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000537 · Cited by 11 · see citing works

Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism

Foll, C. L., & Lutz, T. A. (2020) · Comprehensive physiology · doi:10.1002/j.2040-4603.2020.tb00140.x · Cited by 10 · see citing works

The Structure of the CGRP and Related Receptors

Simms, J., Routledge, S. J., Uddin, R., & Poyner, D. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_132 · Cited by 10 · see citing works

The Calcitonin Receptor Gene Is a Candidate for Regulation of Susceptibility to Herpes simplex Type 1 Neuronal Infection Leading to Encephalitis in Rat

Abdelmagid, N., Bereczky-Veress, B., Guerreiro‐Cacais, A. O., Bergman, P., Luhr, K. M., Bergström, T. B., Sköldenberg, B., Piehl, F., Olsson, T. P., & Diez, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002753 · Cited by 10 · see citing works

Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins

Kuwasako, K., Kitamura, K., Nagata, S., & Kato, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.097 · Cited by 10 · see citing works

The processing intermediate of human amylin, pro-amylin(1–48), has in vivo and in vitro bioactivity

Mazzini, G., Foll, C. L., Boyle, C. N., Garelja, M. L., Zhyvoloup, A., Miller, M. E. T., Hay, D. L., Raleigh, D. P., & Lutz, T. A. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107201 · Cited by 9 · see citing works

Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment

Zong, L., Zhang, Z., Li, X., Jie, J., Jiang, X., Wang, Z., Liu, W., Shen, X., Feng, X., Huang, Y., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01120 · Cited by 8 · see citing works

Islet amyloid polypeptide does not suppress pancreatic cancer

Taylor, A. J., Panzhinskiy, E., Orban, P. C., Lynn, F. C., Schaeffer, D. F., Johnson, J. D., Kopp, J. L., & Verchere, C. B. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101667 · Cited by 7 · see citing works

Selektiv N‐methylierte lösliche IAPP‐Mimetika als potente IAPP‐Rezeptoragonisten und nanomolare Inhibitoren der Selbstassoziation von IAPP und Aβ40

Yan, L.-M., Velkova, A., Tatarek‐Nossol, M., Rammes, G., Sibaev, A., Andreetto, E., Kracklauer, M., Bakou, M., Malideli, E., Göke, B., et al. (2013) · Angewandte Chemie · doi:10.1002/ange.201302840 · Cited by 6 · see citing works

Understanding Amylin Receptors

Just, R., Simms, J., Furness, S. G. B., Christopoulos, A., & Sexton, P. M. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_3 · Cited by 7 · see citing works

Calcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6 · see citing works

The Molecular Physiopathogenesis of Islet Amyloidosis

Bhowmick, D. C., Singh, S., Trikha, S., & Jeremic, A. M. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_62 · Cited by 8 · see citing works

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer’s Disease

Servizi, S., Corrigan, R. R., & Casadesús, G. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200318151146 · Cited by 6 · see citing works

Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56

Christopoulos, G., Perry, K. J., Morfis, M. M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999)

Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product

Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486 · see citing works

Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs)

Fischer, J. A., Muff, R., & Born, W. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300455 · Cited by 36 · see citing works

Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and

Sexton, P. M., Environment, H. C., Tilakaratne, N., Christopoulos, G., Zumpe, E. T., Foord, S. M., & Sexton, P. M. (2016)

Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment

Tilakaratne, N., Christopoulos, G., van der Westhuizen, E. T., Foord, S. M., & Sexton, P. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39040-8 · Cited by 165 · see citing works